DG

David Michael Goldstein

RA Roche Palo Alto: 24 patents #3 of 347Top 1%
PB Principia Biopharma: 16 patents #2 of 26Top 8%
S( Syntex (U.S.A.): 15 patents #20 of 599Top 4%
CT Center For Innovative Technology: 2 patents #33 of 206Top 20%
📍 Redwood City, CA: #83 of 5,061 inventorsTop 2%
🗺 California: #5,977 of 386,348 inventorsTop 2%
Overall (All Time): #40,052 of 4,157,543Top 1%
59
Patents All Time

Issued Patents All Time

Showing 51–59 of 59 patents

Patent #TitleCo-InventorsDate
6506749 7-oxo-pyridopyrimidines (I) Jian Jeffrey Chen, James Patrick Dunn, Julie Anne Lim 2003-01-14
6479507 p38 MAP kinase inhibitors Soan Cheng, Teresa Alejandra Trejo Martin, Eric Brian Sjogren 2002-11-12
6451804 Heteroalkylamino-substituted bicyclic nitrogen heterocycles James Patrick Dunn, Lawrence Emerson Fisher, William I. Harris, Christopher Huw Hill, Ian Edward David Smith +1 more 2002-09-17
6444696 Pyrazole derivatives P38 MAP kinase inhibitors Sharada Labadie, David Mark Rotstein, Eric Brian Sjogren, Francisco Xavier Talamas 2002-09-03
6376527 Pyrazole derivatives-p38 map kinase inhibitors Sharada Labadie, David Mark Rotstein, Eric Brian Sjogren, Francisco Xavier Talamas 2002-04-23
6316464 P38 MAP kinase inhibitors Soan Cheng, Teresa Alejandra Trejo Martin, Eric Brian Sjogren 2001-11-13
6316466 Pyrazole derivatives P-38 MAP kinase inhibitors Sharada Labadie, David Mark Rotstein, Eric Brian Sjogren, Francisco Xavier Talamas 2001-11-13
5639782 Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors T. Y. Shen, Diane M. Gingrich 1997-06-17
5530141 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase T. Y. Shen 1996-06-25